hiPSC-Derived Intestinal Organoids in Pharmacokinetic Resear
2026-06-28
This article examines a recent study establishing a direct 3D protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) for pharmacokinetic studies. The findings advance human-relevant in vitro drug absorption and metabolism models, with practical implications for benchmarking compounds such as Phenacetin.
Nicotinamide Adenine Dinucleotide (NAD+): Applied Workflows
2026-06-27
Nicotinamide Adenine Dinucleotide (NAD+) from APExBIO powers next-generation assays in metabolic signaling and DNA damage response, enabling precise modulation of autophagy and protein deacetylation. Discover protocol optimizations and troubleshooting strategies that translate recent mechanistic insights into robust, reproducible results.
NEXMIF Overexpression Drives ASD-like Behaviors via Neuronal
2026-06-26
This study demonstrates that overexpression of the X-linked NEXMIF gene in mice induces autism-like behaviors and significant alterations in neuronal structure and gene expression. The findings offer novel mechanistic insight into how NEXMIF duplication can contribute to ASD, highlighting both behavioral and molecular consequences relevant for neurodevelopmental research.
Linezolid (SKU A5181): Reliable Oxazolidinone for Antimicrob
2026-06-26
This article offers practical, evidence-based guidance for deploying Linezolid (SKU A5181) in cell viability, proliferation, and cytotoxicity assays. Drawing from validated literature and real-world laboratory scenarios, it addresses challenges in reproducibility, protocol optimization, and supplier selection—demonstrating why Linezolid remains a gold standard for Gram-positive antimicrobial research.
CAFs Drive Chemoresistance in Prostate Cancer via ANGPTL4-IQ
2026-06-25
This study reveals how cancer-associated fibroblasts (CAFs) induce chemoresistance in prostate cancer by promoting mitochondrial biogenesis and oxidative metabolism through the ANGPTL4-IQGAP1 axis. The findings uncover a paracrine signaling mechanism that reduces chemosensitivity and suggest new therapeutic targets for overcoming drug resistance.
Polygodial as a TRPA1 Channel Activator: Protocols & Innovat
2026-06-25
Polygodial empowers researchers to precisely activate TRPA1 channels in sensory neuron and epithelial models, unraveling Ca2+/NFAT-driven inflammatory pathways. Its rapid DMSO solubility and robust signal modulation make it the compound of choice for reproducible ion channel research and neurophysiology workflows.
TPPU and sEH Inhibition: Unraveling the Liver-Bone Axis in R
2026-06-24
Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, enables new frontiers in bone metabolism and chronic inflammation research by targeting the liver-bone signaling axis. This in-depth analysis reveals mechanistic insights and practical applications distinct from existing content.
VE-822 ATR Inhibitor: Selective DNA Damage Response Modulati
2026-06-23
VE-822 is a potent ATR inhibitor with an IC50 of 0.019 μM, enabling selective DNA damage response inhibition in cancer models. Its unique mechanism sensitizes pancreatic ductal adenocarcinoma (PDAC) cells to chemoradiotherapy while sparing normal tissue. This dossier details VE-822’s molecular action, validated research protocols, and practical limitations for advanced cancer research.
3-Bromopyruvate and Cetuximab: Overcoming CRC Resistance via
2026-06-23
This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab induces autophagy-dependent ferroptosis and apoptosis in colorectal cancer cells, effectively overcoming both intrinsic and acquired drug resistance. The findings highlight the mechanistic restoration of FOXO3a signaling and suggest new strategies for targeting refractory metastatic colorectal cancer.
Exercise-Induced Extracellular Vesicles Enhance Amyloid Clea
2026-06-22
This study uncovers how swimming exercise increases skeletal muscle-derived extracellular vesicles (SKM-EVs), which are taken up by microglia to enhance amyloid-beta plaque clearance in Alzheimer’s disease (AD) mouse models. The findings reveal a novel mechanism linking peripheral muscle activity to central amyloid pathology, highlighting extracellular vesicles as potential therapeutic mediators for cognitive dysfunction in AD.
Cy5 NHS ester(Et): Technical Guide for Biomolecule Labeling
2026-06-22
Cy5 NHS ester(Et) addresses the need for stable and high-purity fluorescent labeling of primary amines in proteins and other biomolecules, particularly in workflows such as immunofluorescence staining and flow cytometry. It should be avoided in ethanol-based protocols and for applications requiring long-term storage of dye solutions, as per product stability guidelines.
PRMT5-Regulated Splicing Reveals Glutamine Metabolism Vulner
2026-06-21
This study uncovers a spliceosomal and metabolic vulnerability in MYCN-amplified neuroblastoma, showing that PRMT5 inhibition disrupts both RNA splicing and glutamine metabolism. The findings establish the epitranscriptome and metabolic pathways as convergent nodes for targeted intervention, with implications for preclinical cancer metabolism research workflows.
Modified Ethanol Injection Enhances mRNA Lipoplex Delivery E
2026-06-20
Tang et al. introduce a modified ethanol injection (MEI) technique to efficiently generate mRNA lipoplexes for delivery in vitro and in vivo. Their findings highlight improved protein expression and immunogenicity, offering a streamlined approach to mRNA delivery that is relevant for vaccine and therapeutic applications.
Practical Guide: Cy7 NHS Ester for Protein Labeling and Imag
2026-06-19
Cy7 NHS ester offers a sulfonated, water-soluble near-infrared dye solution for labeling amino groups in proteins and peptides, supporting non-destructive in vivo and in vitro imaging workflows. It is best suited for applications requiring minimal protein denaturation and high signal retention, but not for workflows needing long-term dye solution storage or targets lacking accessible amino groups.
Magnetic CSNP-Exosome Hydrogel Restores Bladder Function via
2026-06-19
This study demonstrates that a magnetic chitosan nanoparticle-exosome hydrogel enhances bladder function in diabetic bladder dysfunction by activating the FAK-p38 MAPK-GATA4 signaling axis in adipose-derived mesenchymal stromal cells. The findings offer mechanistic insight into regenerative strategies for chronic urological disease and highlight new avenues for targeted cell therapy.
508 records 17/34 page Previous Next First page 上5页 1617181920 下5页 Last page